SCHEMBL3727320

SCHEMBL3727320

C#CCNc1nc(C(N)=O)cc(-c2ccc(Br)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 3/20 0.43
FPR2 P25090 1/20 0.43
GRM2 Q14416 1/20 0.41
MCL1 Q07820 4/20 0.40
KDM4E B2RXH2 3/20 0.40
AGTR1 P30556 1/20 0.40
CASP1 P29466 1/20 0.38
LMNA P02545 1/20 0.37
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
GLA P06280 2/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PYCR1 P32322 1/20 0.35
ADORA3 P0DMS8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1734467 0.88 KDM4E (0.53) KDM4ECASP1LMNAALDH1A1HPGD
SCHEMBL3722028 0.82 GRM2 (0.45) SCN9AFPR2GRM2MCL1KDM4E
SCHEMBL3723259 0.82 PTGS1 (0.48) SCN9AFPR2GRM2MCL1KDM4E
SCHEMBL3727322 0.79 AGTR1 (0.43) MCL1KDM4EAGTR1LMNAALDH1A1
SCHEMBL1734170 0.78 VCP (0.51) KDM4ELMNAALDH1A1HPGDGLA
SCHEMBL3723027 0.76 SCN9A (0.57) SCN9AKDM4ELMNAALDH1A1GAA
SCHEMBL3727139 0.75 GRM2 (0.42) SCN9AFPR2GRM2MCL1KDM4E
SCHEMBL3720301 0.74 KMT2A (0.43) MCL1CASP1HPGD
SCHEMBL3720116 0.74 SCN9A (0.47) SCN9AGRM2KDM4EAGTR1LMNA
SCHEMBL3718666 0.74 KDM4E (0.55) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8614201-B2 Heterocyclic amides as modulators of TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2013-12-24 US disclosed
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 WO disclosed